In summary, NUSAP1 was identified as a target which could mediate NAFLD progression from no-fibrosis to advanced fibrosis which contributed to the NAFLD-HCC eventually. The gene discussed is NUSAP1; the disease is metabolic dysfunction-associated steatotic liver disease.